期刊文献+

3,5-二甲基-4-羟基苯甲腈的合成研究 被引量:3

A study on synthesis of 3,5-dimethyl-4-hydroxybenzonitrile
下载PDF
导出
摘要 以3,5-二甲基-4-羟基苯甲醛和盐酸羟胺为原料,分别在甲酸、乙酸和N,N-二甲基甲酰胺(DMF)中一步反应合成了3,5-二甲基-4-羟基苯甲腈。以DMF为溶剂的反应效果最好,最佳条件下收率达90%以上,粗品含量98%以上。 A one-pot synthesis of 3,5-dimethyl-4-hydroxybenzonitrile from 3,5-dimethyl-4-hydroxybenzaldehyde and hydroxyamine hydrochloride in solvents such as formic acid, acetic acid, and N, N-dimethylformamide (DMF) is studied. The yields are optimal if in DMF, and the optimization of reaction conditions is carried out. Under such optimum conditions the yield of the nitrile can be 93% ,with purity of above 98% ,which are determined by HPLC.
出处 《现代化工》 CAS CSCD 北大核心 2010年第3期44-45,47,共3页 Modern Chemical Industry
基金 浙江工业大学浙西分校科研启动经费资助项目
关键词 3 5-二甲基-4-羟基苯甲醛 3 5-二甲基-4-羟基苯甲腈 盐酸羟胺 N N-二甲基甲酰胺 合成 3, 5-dimethyl-4-hydroxybenzaldehyde 3, 5-dimethyl-4-hydroxybenzonitrile hydroxyamine hydrochloride N,N-dimethylformamide synthesis
  • 相关文献

参考文献19

  • 1姚鹏,宫平.Etravirin[J].中国药物化学杂志,2008,18(4):318-318. 被引量:2
  • 2朱骏杰,曹江营,展鹏,赵翠荣,刘新泳.新一代非核苷类HIV-1逆转录酶抑制剂研究进展[J].中国新药杂志,2009,18(3):206-212. 被引量:3
  • 3De Corte B, et al. HIV replication inhibiting pyrimidines: US, 2003114472 [ P ]. 2003 - 06 - 19.
  • 4张秋材,丁敏,李文忠,等.制备对氰基苯酚类化合物的方法:中国,1442404[P].2003-09-17.
  • 5Sterling Winthrop Inc. (New York). 1,2,4-Oxadiazolyl-phenoxyal-kylisoxasoles and their use as antiviral agents : US, 5464848 [ P ]. 1995 - 11 - 07.
  • 6朱崇泉,吴艳俊,张弈华,曹庆先.1,2,4-□二唑-苯氧烷基取代的异□唑衍生物、其制备方法和抗病毒应用:中国,1687060[P].2005-10-26.
  • 7Schering Co. Method for controlling plant growth: US, 3326658 [ P]. 1967 -06 -20.
  • 8Smith W E. Formylation of aromatic compounds with hexamethylenetetraamine and trifluoroacetic acid [J]. J Org Chem, 1972,37 (24) :3972 -3973.
  • 9Weisse L,Neunteufel R, Strutz H. Process for selective preparation of hydroxybenzaldehydes [ J ] : US 5395978 [ P ]. 1995 - 03 - 07.
  • 10Boldron C, Gamez P, Tooke D M, et al. Copper-mediated selective oxidation of a C-H bond [ J ]. Angew Chem Int Ed Engl,2005,44: 3585 - 3587.

二级参考文献47

  • 1陈先红,谢蓝.抗耐药性HIV非核苷类逆转录酶抑制剂的研究进展[J].中国药物化学杂志,2006,16(3):182-187. 被引量:4
  • 2田金如,聂新永,李永伟,刘玉真,尚振华,李春静.PEG-600在有机合成中的应用及前景[J].河北化工,2006,29(10):4-7. 被引量:4
  • 3DE COR, DE JON, HEE, et al. Preparation of arylaminopyrimidinas as inhibitors of HIV replication: WO, 2000/027825 [P] .2000 - 05 - 18.
  • 4DON W, LUD, DE COR, et al. Evolution of anti-HIV drug canditates. Part 3 : diarylpyrimidine (DAPY) analogues [ J ]. Bio Med Chem Lett, 2001, 11(17) : 2235 - 2239.
  • 5US FDA. FDA hbelling information[ EB/OL]. [2008 - 01 - 18]. http://www. fda. gov/cder/foi/label/2008/0221871b1.pdf.
  • 6JOS V M, PED C, BEA G, et al. Efficacy and safety of TMC125(etravirine) in treatment-experienced HIV-1-infected patients in DUET-1:24-week results from a randomised, double-blind, placebo-controlled trial [J ]. The Lancet, 2007, 370 (9581) : 29 - 38.
  • 7ADR L, THO C, BON C, et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2:24-week results from a randomised, double-blind, placebo-controlled trial [J ]. The Lancet, 2007, 370 ( 9581 ) : 39 - 48.
  • 8CAMP1AN| G, RAMUNNO A, MAGA G, et al. Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives[J]. Curt Pharm Des, 2002, 8(8): 615 -657.
  • 9SLUIS-CREMER N, TEMIZ NA, BAHAR I. Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding[ J]. Curr HIV Res, 2004,2(4): 323-332.
  • 10PEREZ-MOLINA JA. Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national muhicenter prospective study in 1 , 033 HIV-infeeted patients [ J ]. HIV Clin Trials ,2002,3 ( 4 ) :279 - 286.

共引文献13

同被引文献49

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部